Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antimicrobials from an epigenetics based fungal metabolite screening program

Antimicrobials from an epigenetics based fungal metabolite screening program

US Patent 10377733 · Granted Aug 13, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of Acanthamoeba or Balamuthia trophozoites and/or cysts2025
Dendrilla membranosa compounds, derivatives thereof, and uses thereof2025
Dendrilla membranosa compounds, derivatives thereof, and uses thereof2025
Antarctic tunicate Synoicum species-derived alkaloids and methods of treatment2025
Epigenetic modification of fungi and uses thereof2024
Epigenetic modification of fungi and uses thereof2024
Epigenetic modification of fungi and uses thereof2024
Methods for the treatment of Mycobacterium infections2024
Methods for the treatment of inflammation2023
Dendrilla membranosa compounds, derivatives thereof, and uses thereof2023
Dendrilla membranosa compounds, derivatives thereof, and uses thereof2023
Methods and compositions for modulating complex mixtures by selective deletion c2022